Amgen boosts drug stocks 2nd day
4th Nov 2005, 23:30 GMT
Amgen boosted drug stocks for the 2nd straight sessi, propelled by positive drug data for its investigational colorectal cancer drug panitumumab.
Amgen boosts drug stocks 2nd day related news:
- United States drug manufacturer Amgen Inc has defended its decision ... — Top Stories Photos - AFP on Yahoo! News Photos
- Experimental cancer drug results sends biotech companies' stocks soaring — SacBee -- Business
- Sponsorship of top cycling races has taken a new twist with ... — Sports Photos - AFP on Yahoo! News Photos
- Abgenix-Amgen cancer drug gets favorable test result — SacBee -- Business
- Amgen, Abgenix Shares Rise on Trial News — WTOP Radio - Business News
- Abgenix, Amgen cancer treatment test successful — bizjournals.com Health Care:Pharmaceuticals headlines
- Amgen, Not Merck, Is the Real Drug Story — RealMoney by TheStreet.com
- Abgenix, Amgen stock up on successful cancer treatment test — bizjournals.com Health Care:Pharmaceuticals headlines
- Drug stocks climb as King gains on DOJ deal — Government/ Industry Regulation News from StratCenter.com
- Drug stocks slip on J&J merger woes — Bio-Technology News from StratCenter.com
Latest news from Bio-Technology News from StratCenter.com:
- IBT Labs Invests $2 mln to Expand Pharmaceutical Services Division
- Mercury Computer Systems Collaborates with Boston Univ to Deliver Biotech Application on the Cell BE Processor
- Nabi Biopharmaceuticals and 3rd Point Reach Agreement
- Epratuzumab and Rituximab Have Different Modes of Action
- avVaa World Health Care Products Signs New Spokesman
- China Biopharma Delivers 1.5 mln Doses of Flu Vaccine in China
- Osteologix Appoints Jeremy Curnock Cook to its Board
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma
- Medarex to Receive Milestone Payment from Amgen
- Arqule Early Cancer Study Shows Progress